Glutaminyl cyclases (QC) 1 (EC 2.3.2.5) are acyltransferases present in animals and plants that catalyze the conversion of N-terminal glutaminyl residues into pyroglutamic acid with the concomitant liberation of ammonia (Scheme 1). Several peptide hormones and proteins carry N-terminal pyroglutamyl residues. Previously, the formation of N-terminal pyroglutamate from glutamine was assumed to proceed spontaneously (1). However, the QCs were identified more recently as catalysts of the reaction in both mammals and plants (2-5). Generally, QCs from both mammalian and plant sources appear to be very similar monomeric proteins that are expressed in the secretory pathways and have similar molecular masses, ϳ33 and ϳ40 kDa, respectively (6, 7). Their primary structures, however, reveal no sequence homology, and the enzymes feature completely different folding patterns. Whereas plant QC consists almost solely of -sheet structure, mammalian QCs are predicted to possess an ␣/-fold (8 -10). Furthermore, plant QC does not share sequence or structural homology to other plant enzymes, belonging, apparently, to a separate enzyme subfamily (4). Mammalian QCs, however, exhibit remarkable homology toward bacterial aminopeptidases, suggesting their evolutionary origin in this protein family (9).Investigating the substrate specificity of both enzymes, we recently found differences between papaya and human QC (24). Although the catalysis of cyclization of and the inhibition by modified N-terminal residues were quite different, both enzymes catalyzed the cyclization of oligopeptides with similar specificity rate constants. Moreover, they also catalyzed the formation of a five-membered lactam ring from L--homoglutaminyl peptides. Based on the present state of knowledge, it is assumed that plant and animal QCs catalyze the formation of N-terminal pyroglutamic acid (pGlu) residues by enabling the intramolecular cyclization of the glutaminyl residue in a noncovalent manner (11,12). However, the results of the substrate specificity study revealed differences in substrate recognition by both enzymes.Thus, a more detailed analysis of the inhibition pattern of plant and human QCs should help to deepen our understanding of QC catalysis. To date, however, systematic inhibitor data exist only for plant QC, which is competitively inhibited by peptides containing an N-terminal proline residue (13), whereas human QC was shown to be inactivated by 1,10-phenanthroline and reduced 6-methylpterin (3). Thus, we investigated the inhibiting potency of heterocyclic compounds from different structural classes. Among them, imidazole and structurally related compounds were found to be the most efficient competitive inhibitors of human QC. The data provide the first insights into enzyme/inhibitor interactions, offer clues for further optimization of the inhibitory structure, and reveal novel aspects of human QC catalysis.